Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: Data from the IPF-PRO Registry
Related Posts
Ahmed A, Yadav P, Jensen M, Geasland K, Swamy J, Spitz DR, Abel ED, Jalal D, Dayal S. Mitochondrial oxidants promote platelet activation and thrombotic[...]
Kwan K, Labora A, Chen F, Solorzano W, Gonzalez D, Orji W, Russell T. DaRE to Approach Differently: Teaching the Digital Anorectal Examination Through a[...]
Shammas R, Gudino-Rosales S, Kneiber D, Sarantopoulos GP, Aung T. Facial Swelling in a Young Adult With Type 1 Diabetes: Morbihan Disease as a Scleroderma[...]